Cardiotoxicity of Anthracyclines

Frontiers in Cardiovascular Medicine - Switzerland
doi 10.3389/fcvm.2020.00026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Cumulative Anthracycline Exposure and Risk of Cardiotoxicity; A Danish Nationwide Cohort Study of 2440 Lymphoma Patients Treated With or Without Anthracyclines

British Journal of Haematology
Hematology
2018English

Cancer and Cardiovascular Disease: The Use of Novel Echocardiography Measures to Predict Subsequent Cardiotoxicity in Breast Cancer Treated With Anthracyclines and Trastuzumab

Current Heart Failure Reports
Emergency MedicineCardiovascular MedicinePhysiologyCardiology
2014English

Evidence for Association of SNPs inABCB1andCBR3, but notRAC2, NCF4, SLC28A3orTOP2B, With Chronic Cardiotoxicity in a Cohort of Breast Cancer Patients Treated With Anthracyclines

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2016English

Regional Myocardial Edema Detected by T2 Mapping Is a Feature of Cardiotoxicity in Breast Cancer Patients Receiving Sequential Therapy With Anthracyclines and Trastuzumab

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2014English

A New Class of Biosynthetic Anthracyclines: Anthracyclinone Glucuronides.

Journal of Antibiotics
Drug DiscoveryPharmacology
1987English

Fluorouracil Cardiotoxicity.

BMJ
1978English

Anthracycline Cardiotoxicity

2012English

The Cardiotoxicity of Eosinophils.

Postgraduate Medical Journal
Medicine
1983English

Toxicogenomic Analysis of Cardiotoxicity in Rats

Genomics Insights
BiochemistryGeneticsCell BiologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy